Shares of the thinly traded micro-cap biopharma Rockwell Medical Inc (NASDAQ: RMTI
) were advancing solidly Tuesday before falling back into the red.
Rockwell Medical (RMTI
), down 28% after its 5.83M share spot secondary offering priced at $3 per share...
Rockwell Medical Inc (NASDAQ: RMTI
), a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease, announced yesterday that it has named Angus Smith as its new chief financial officer effective at the end of November 2018.
Zubiri maintained that the attack was meant for RMTI
RN, 8/18/12 LMT, RMTI
9/8/12 10/13/12 6/29/12 Albuquerque NM Board of 8.24 NM Board of Nursing Diversion Nursing, Program Diversion Conference Program 8/10/12 Albuquerque Empowering Your 7.3 Jean M.
(KAM624) ROBERT CHIOINI, CEO of ROCKWELL MEDICAL TECHNOLOGIES INC (RMTI
), describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward.
* Rockwell Medical, Inc.(NASDAQ: RMTI
) dropped 14.7% to close at $2.66.